Colgate-Palmolive Company $CL Shares Sold by Candriam S.C.A.

Key Points

• Candriam S.C.A. reduced its stake in Colgate-Palmolive Company by 2.6%, holding 340,552 shares worth approximately $31.91 million after selling 9,121 shares in the most recent quarter.
• The company reported earnings per share of $0.92 for the last quarter, surpassing analyst expectations of $0.89, with revenue of $5.11 billion, exceeding predictions of $5.03 billion.
• Colgate-Palmolive declared a quarterly dividend of $0.52 per share, reflecting an annualized yield of 2.4% and a payout ratio of 58.43%.

Candriam S.C.A. lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 2.6% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 340,552 shares of the company's stock after selling 9,121 shares during the quarter. Candriam S.C.A.'s holdings in Colgate-Palmolive were worth $31,910,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of CL. Cornerstone Wealth Management LLC grew its holdings in shares of Colgate-Palmolive by 1.2% during the first quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company's stock valued at $847,000 after buying an additional 110 shares in the last quarter. Aberdeen Wealth Management LLC grew its stake in Colgate-Palmolive by 0.6% in the fourth quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company's stock valued at $1,877,000 after purchasing an additional 125 shares in the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO grew its stake in Colgate-Palmolive by 4.0% in the first quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company's stock valued at $317,000 after purchasing an additional 130 shares in the last quarter. Continuum Advisory LLC grew its stake in Colgate-Palmolive by 17.2% in the fourth quarter. Continuum Advisory LLC now owns 893 shares of the company's stock valued at $81,000 after purchasing an additional 131 shares in the last quarter. Finally, KFG Wealth Management LLC grew its stake in Colgate-Palmolive by 1.5% in the first quarter. KFG Wealth Management LLC now owns 8,835 shares of the company's stock valued at $828,000 after purchasing an additional 131 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

CL stock opened at $85.7190 on Wednesday. The stock has a 50-day moving average price of $87.95 and a two-hundred day moving average price of $89.95. The stock has a market cap of $69.28 billion, a PE ratio of 24.08, a price-to-earnings-growth ratio of 4.38 and a beta of 0.35. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 1 year low of $82.40 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. The company had revenue of $5.11 billion during the quarter, compared to analysts' expectations of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.91 EPS. Equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a dividend of $0.52 per share. The ex-dividend date was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.43%.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. UBS Group lowered their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research note on Thursday, July 17th. Wells Fargo & Company lowered their target price on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday, August 4th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Citigroup lowered their target price on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. Finally, JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Seven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $98.92.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.